Trademarkia Logo

Canada

C$
ZAVIMCY
REGISTERED

on 9 Oct 2020

Last Applicant/ Owned by

H. LUNDBECK A/S

Ottiliavej 92500 Valby

DK

Serial Number

1906211 filed on 26th Jun 2018

Registration Number

TMA1084328 registered on 9th Oct 2020

Registration expiry Date

9th Oct 2030

Correspondent Address

SMART & BIGGAR LP

1100-150 York StreetToronto

ONTARIO

CA

M5H3S5

ZAVIMCY

Trademark usage description

pharmaceutical preparations, substances and vaccines for the prevention and treatment of disorders and diseases in, generated by or acting on the cent Read More

Classification Information


Class [005]
Pharmaceutical preparations, substances and vaccines for the prevention and treatment of disorders and diseases in, generated by or acting on the central nervous system, namely, dementia, Alzheimer's disorder and disease, dizziness, seizures, stroke, depression, cognitive impairment, cognitive disorders and diseases, mood disorders, psychosis, anxiety, apathy, epilepsy, Lennox-Gastaut syndrome (LGS), sclerosis, porphyria, Huntington's disorder and disease, insomnia, Parkinson's disorder and disease, falls, movement disorders and diseases, tremor, schizophrenia, bipolar disorder and disease, mania, ADHD, PTSD, agitation, aggression, autism, melancholy, OCD, Tourette's syndrome, progressive supranuclear palsy (PSP), restlessness, akathisia, fatigue, somnolence, nausea, cancer, migraine, pain, alcoholism and dependency; pharmaceutical preparations and substances for the prevention and treatment of disorders and diseases in, generated by or acting on the central nervous system, namely dementia, Alzheimer's disorder and disease, dizziness, seizures, stroke, depression, cognitive impairment, cognitive disorders and diseases, mood disorders, psychosis, anxiety, apathy, epilepsy, Lennox-Gastaut syndrome (LGS), sclerosis, porphyria, Huntington's disorder and disease, insomnia, Parkinson's disorder and disease, falls, movement disorders and diseases, tremor, schizophrenia, bipolar disorder and disease, mania, ADHD, PTSD, agitation, aggression, autism, melancholy, OCD, Tourette's syndrome, progressive supranuclear palsy (PSP), restlessness, akathisia, fatigue, somnolence, nausea, cancer, migraine, pain, alcoholism and dependency; central nervous system stimulants; pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological disorders and diseases, namely dementia, Alzheimer's disorder and disease, dizziness, seizures, stroke, depression, cognitive impairment, cognitive disorders and diseases, mood disorders, psychosis, anxiety, apathy, epilepsy, Lennox-Gastaut syndrome (LGS), sclerosis, porphyria, Huntington's disorder and disease, insomnia, Parkinson's disorder and disease, falls, movement disorders and diseases, tremor, schizophrenia, bipolar disorder and disease, mania, ADHD, PTSD, agitation, aggression, autism, melancholy, OCD, Tourette's syndrome, progressive supranuclear palsy (PSP), restlessness, akathisia, fatigue, somnolence, nausea, cancer, migraine, pain, alcoholism and dependency; pharmaceutical preparations and substances for the prevention and treatment of dementia, Alzheimer's disorder and disease, dizziness, seizures, stroke, depression, cognitive impairment, cognitive disorders and diseases, mood disorders, psychosis, anxiety, apathy, epilepsy, Lennox-Gastaut syndrome (LGS), sclerosis, porphyria, Huntington's disorder and disease, insomnia, Parkinson's disorder and disease, falls, movement disorders and diseases, tremor, schizophrenia, bipolar disorder and disease, mania, ADHD, PTSD, agitation, aggression, autism, melancholy, OCD, Tourette's syndrome, progressive supranuclear palsy (PSP), restlessness, akathisia, fatigue, somnolence, nausea, cancer, migraine, pain, alcoholism and dependency; diagnostic reagents and agents for medical diagnostic use


Classification kind code

11

Mark Details


Serial Number

1906211

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 190
on 23rd Apr 2020
Registration Pending
Submitted for opposition 42
on 5th Feb 2020
Advertised
Submitted for opposition 26
on 20th Jan 2020
Approved
Submitted for opposition 27
on 20th Jan 2020
Approval Notice Sent
Submitted for opposition 67
on 11th Sept 2019
Agent Name Changed
Submitted for opposition 22
on 29th May 2019
Search Recorded
Submitted for opposition 20
on 29th May 2019
Examiner's First Report
Submitted for opposition 31
on 28th Jun 2018
Formalized
Submitted for opposition 1
on 27th Jun 2018
Created
Submitted for opposition 30
on 26th Jun 2018
Filed